Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：78

作者：

Sorensen, M. ^{[1
]}

Pijls-Johannesma, M. ^{[2
]}

Felip, E. ^{[3
]}

机构：

[1] Finsen Ctr, Dept Oncol, Copenhagen, Denmark

[2] Maastricht Univ, Med Ctr, GROW Res Inst, Dept Radiat Oncol,MAASTRO Clin, Maastricht, Netherlands

[3] Vall Hebron Univ Hosp, Med Oncol Serv, Barcelona, Spain

来源：

ANNALS OF ONCOLOGY | 2010年 / 21卷

关键词：

PHASE-III TRIAL; COLONY-STIMULATING FACTOR; PROPHYLACTIC CRANIAL IRRADIATION; CISPLATIN PLUS ETOPOSIDE; LEUKEMIA GROUP-B; LIMITED-STAGE; THORACIC RADIOTHERAPY; EUROPEAN-ORGANIZATION; ORAL ETOPOSIDE; INTENSIFIED CHEMOTHERAPY;

D O I：

10.1093/annonc/mdq172

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：v120 / v125

页数：6

共 57 条

[1] Platinum versus non-platinum chemotherapy regimens for small cell lung cancer
Amarasena, Isuru U.
Walters, Julia A. E.
Wood-Baker, Richard
Fong, Kwun
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (04):
[2] [Anonymous], 1989, Lung Cancer, DOI DOI 10.1016/0169-5002(89)90156-6
[3] Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: A prospective European organization for research and treatment of cancer-lung cancer group phase III trial-08923
Ardizzoni, A
Tjan-Heijnen, VCG
Postmus, PE
Buchholz, E
Biesma, B
Karnicka-Mlodkowska, H
Dziadziuszko, R
Burghouts, J
van Meerbeeck, JP
Gans, S
Legrand, C
Debruyne, C
Giaccone, G
Manegold, C
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) : 3947 - 3955
[4] Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission
Aupérin, A
Arriagada, R
Pignon, JP
Le Péchoux, C
Gregor, A
Stephens, RJ
Kristjansen, PEG
Johnson, BE
Ueoka, H
Wagner, H
Aisner, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) : 476 - 484
[5] BLEEHEN NM, 1989, BRIT J CANCER, V59, P584
[6] A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE IN SMALL-CELL LUNG-CANCER (SCLC) .1. SURVIVAL AND PROGNOSTIC FACTORS
BLEEHEN, NM
GIRLING, DJ
MACHIN, D
STEPHENS, RJ
BARLEY, VL
BULLIMORE, JA
WHITE, RJ
BLEEHAN, NM
WILLIAMS, MV
BREDIN, CP
DAVIDSON, AR
WILLIAMS, TJ
ASH, DV
CLOSE, HJ
JOSLIN, CA
MUERS, MF
STONE, J
ASHFORD, RF
DISCHE, S
DUNPHY, EP
FERMONT, DC
GROSCH, E
MAHER, EJ
SAUNDERS, MI
ADAM, RJ
ALCOCK, CJ
BENSON, MK
HOPKIN, JM
LANE, DJ
HUNTER, AM
[J]. BRITISH JOURNAL OF CANCER, 1993, 68 (06) : 1150 - 1156
[7] 70 GY thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: Analysis of cancer and leukemia group B study 39808
Bogart, JA
Herndon, JE
Lyss, AP
Watson, D
Miller, AA
Lee, ME
Turrisi, AT
Green, MR
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (02): : 460 - 468
[8] Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma
Bonner, JA
Sloan, JA
Shanahan, TG
Brooks, BJ
Marks, RS
Krook, JE
Gerstner, JB
Maksymiuk, A
Levitt, R
Mailliard, JA
Tazelaar, HD
Hillman, S
Jett, JR
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2681 - 2691
[9] Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosis
Buchholz, Erika
Manegold, Christian
Pilz, Lothar
Thatcher, Nick
Drings, Peter
[J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (01) : 51 - 58
[10] IMPORTANCE OF RADIATION-DOSE IN ACHIEVING IMPROVED LOCO-REGIONAL TUMOR-CONTROL IN LIMITED STAGE SMALL-CELL LUNG-CARCINOMA - AN UPDATE
CHOI, NC
CAREY, RW
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (02): : 307 - 310

← 1 2 3 4 5 6 →